Aldeyra Therapeutics, Inc. - ALDX
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 20
Latest filed: Jul 15, 2026
| Form | Count |
|---|---|
| 4 | 11 |
| 8-K | 6 |
| SCHEDULE 13G/A | 3 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Jul 15, 2026 | 8-K | Jul 14, 2026 | 0001193125-26-304880 | View |
| Jun 11, 2026 | 4 | Jun 09, 2026 | 0001193125-26-267587 | View |
| Jun 11, 2026 | 4 | Jun 09, 2026 | 0001193125-26-267600 | View |
| Jun 11, 2026 | 4 | Jun 09, 2026 | 0001193125-26-267605 | View |
| Jun 11, 2026 | 4 | Jun 09, 2026 | 0001193125-26-267611 | View |
| Jun 11, 2026 | 4 | Jun 09, 2026 | 0001193125-26-267623 | View |
| Jun 11, 2026 | 4 | Jun 09, 2026 | 0001193125-26-267629 | View |
| Jun 11, 2026 | 4 | Jun 09, 2026 | 0001193125-26-267634 | View |
| Jun 10, 2026 | 8-K | Jun 09, 2026 | 0001193125-26-264514 | View |
| Jun 05, 2026 | 4 | Jun 03, 2026 | 0001193125-26-259637 | View |
| May 15, 2026 | SCHEDULE 13G/A | — | 0001193125-26-226558 | View |
| May 01, 2026 | 8-K | May 01, 2026 | 0001193125-26-199157 | View |
| Apr 20, 2026 | 8-K | Apr 20, 2026 | 0001193125-26-164198 | View |
| Apr 01, 2026 | 8-K | Apr 01, 2026 | 0001193125-26-137984 | View |
| Mar 31, 2026 | 4 | Mar 27, 2026 | 0001193125-26-134631 | View |
| Mar 26, 2026 | SCHEDULE 13G/A | — | 0000102909-26-000589 | View |
| Mar 20, 2026 | 4 | Mar 19, 2026 | 0001193125-26-117675 | View |
| Mar 19, 2026 | 4 | Mar 18, 2026 | 0001193125-26-116247 | View |
| Mar 17, 2026 | 8-K | Mar 17, 2026 | 0001193125-26-109511 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | — | 0001193125-26-054525 | View |